Quin Wills (L) and Jack O’Meara, Ochre Bio
A liver disease upstart with some global connections and a new R&D strategy reaps a $30M launch round
LONDON — Back when Jack O’Meara and Quin Wills were initially setting up Ochre Bio, they jumped from their home base in the UK to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
